Alignment Healthcare Inc. logo

Alignment Healthcare Inc.

ALHC | NASDAQ
Chart Builder DCF Calculator
$8.33
-$0.02 (-0.24%)
At close: Sep 21, 2026, 4:00 PM ET
$8.33
$0 (-0.02%)
After-hours: Sep 21, 2026, 7:57 PM ET
-0.24%

Rating

Updated: Aug 24, 2026
55.2
Fundamentals Strong
Market Sentiment Bullish
Moat Narrow

Key Statistics

Market Data

Market Cap $1.73B
1D Range
8.03 8.38
52W Range
8.03 25.12

Valuation (TTM)

PE 43.84
PB 6.52
EV/EBITDA 12.03

Valuation (NTM)

Forward PE 21.58
Forward PEG 0.30
Price Target $19
Loading financial charts...

Profile

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services...

Sector Healthcare
Employees 1,849
IPO Date Mar 25, 2021
Fiscal Year January - December

Latest News

Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

4 days ago · globenewswire.com

Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

4 days ago · globenewswire.com

Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures

5 days ago · globenewswire.com

ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures
Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

5 days ago · globenewswire.com

Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC

6 days ago · businesswire.com

Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors With Losses to Learn More About the Investigation

8 days ago · globenewswire.com

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors With Losses to Learn More About the Investigation
Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

12 days ago · globenewswire.com

Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
Kaplan Fox Reminds Alignment Healthcare, Inc. (ALHC) Investors of an Investigation into Potential Securities Law Violations

13 days ago · newsfilecorp.com

Kaplan Fox Reminds Alignment Healthcare, Inc. (ALHC) Investors of an Investigation into Potential Securities Law Violations
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Protect Their Rights Amid a Securities Investigation

13 days ago · globenewswire.com

Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Protect Their Rights Amid a Securities Investigation
Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations

14 days ago · newsfilecorp.com

Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations

Earnings

Next Earnings
Oct 29, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$19
Upside
+128.09%
Buy (4)
Hold (1)
Sell (0)
Analyst Details

© 2026 bestshares.com. All rights reserved.